| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 15, 2016
DUBLIN - September 15, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of its Hybrid Closed Loop system pivotal trial results in the...
-
Sep 14, 2016Miniaturized Device Now Available for Use in Patients with Unexplained Syncope and Stroke
DUBLIN - Sept. 14, 2016 - Medtronic plc (NYSE: MDT) today announced it has received Ministry of Health, Labor and Welfare (MHLW) approval of the Reveal LINQ Insertable Cardiac Monitor (ICM) System...
-
Sep 13, 2016Medtronic Foundation Grants Support Organizations Committed
NORTHRIDGE, Calif. - Sept. 13, 2016 - Medtronic Foundation today announced that five community organizations will receive a combined $250,000 in Health Access Grants in recognition of their...
-
Sep 13, 2016IN.PACT Admiral DCB Indication Expansion to Treat Patients with ISR
DUBLIN - Sept. 13, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) as a treatment...
-
Sep 12, 2016Clinical Practice Guidelines from European Society of Cardiology 2016 Reinforce Benefits of Cryoballoon Ablation and Long-Term Cardiac Monitoring
DUBLIN - September 12, 2016 - Two Medtronic plc (NYSE: MDT) innovations were acknowledged in updated guidelines published by the European Society of Cardiology (ESC): cryoballoon ablation for...
-
Sep 8, 2016Company named to the Dow Jones Sustainability North America Index (DJSI North America)
DUBLIN - September 8, 2016 - Medtronic plc (NYSE: MDT) was recognized today as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability North...
-
Sep 6, 2016
DUBLIN - Sept. 6, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced that it will participate in the Morgan Stanley Global Healthcare...
-
Sep 1, 2016iPro2 Professional CGM with Enlite Provides Critical Link Between Glucose Variability and Lifestyle for Improved Diabetes Control
DUBLIN - Sept. 1, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the FDA approval of the Enlitesensor for use with iPro2 Professional Continuous Glucose...
-
Sep 1, 2016
DUBLIN - Sept. 1, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced that it will participate in the Wells Fargo Global Healthcare...
-
Aug 29, 2016First-of-its-Kind Data on EffectivCRT(TM) for Heart Failure Patients with Atrial Fibrillation Presented at ESC
DUBLIN and ROME - Aug. 29, 2016 - Medtronic plc (NYSE:MDT) today announced results from the Cardiac Resynchronization Therapy Efficacy Enhancement (CRTee) study. The study showed that the...